4/2/2025

Lanthanum Carbonate Oral Presentations

Products Affected - Description

- Lanthanum carbonate chewable tablet, Exelan Pharmaceuticals, 1,000 mg, bottle, 90 count, NDC 76282-0478-90
- Lanthanum carbonate chewable tablet, Exelan Pharmaceuticals, 500 mg, bottle, 90 count, NDC 76282-0476-90
- Lanthanum carbonate chewable tablet, Exelan Pharmaceuticals, 750 mg, bottle, 90 count, NDC 76282-0477-90
- Lanthanum carbonate chewable tablet, Teva, 1,000 mg, bottle, 90 count, NDC 00093-5940-98
- Lanthanum carbonate chewable tablet, Teva, 500 mg, bottle, 90 count, NDC 00093-5938-98
- Lanthanum carbonate chewable tablet, Teva, 750 mg, bottle, 90 count, NDC 00093-5939-98

Reason for the Shortage

- Cipla has lanthanum carbonate chewable tablets available.
- Exelan did not provide a reason for the shortage.
- Lupin has lanthanum carbonate chewable tablets available.
- Teva did not provide a reason for the shortage.
- Takeda has Fosrenol chewable tablets and oral powder packs available.

Available Products

- Fosrenol oral powder, Takeda, 1,000 mg, stick pack carton, 90 count, NDC 54092-0257-02
- Fosrenol oral powder, Takeda, 750 mg, stick pack carton, 90 count, NDC 54092-0256-02
- Fosrenol chewable tablet, Takeda, 1,000 mg, bottle, 90 count, NDC 54092-0254-90
- Fosrenol chewable tablet, Takeda, 500 mg, bottle, 90 count, NDC 54092-0252-90
- Fosrenol chewable tablet, Takeda, 750 mg, bottle, 90 count, NDC 54092-0253-90
- Lanthanum carbonate chewable tablet, Cipla USA, 1,000 mg, bottle, 90 count, NDC 69097-0936-98
- Lanthanum carbonate chewable tablet, Cipla USA, 500 mg, bottle, 90 count, NDC 69097-0934-98
- Lanthanum carbonate chewable tablet, Cipla USA, 750 mg, bottle, 90 count, NDC 69097-0935-98
- Lanthanum carbonate chewable tablet, Lupin, 1,000 mg, bottle, 90 count, NDC 68180-0821-47
- Lanthanum carbonate chewable tablet, Lupin, 500 mg, bottle, 90 count, NDC 68180-0819-42
- Lanthanum carbonate chewable tablet, Lupin, 750 mg, bottle, 90 count, NDC 68180-0820-46

Estimated Resupply Dates

- Exelan has lanthanum carbonate 500 mg, 750 mg, and 1,000 mg chewable tablets on back order and the company estimates a release date of second half of 2025.
- Teva has lanthanum carbonate 500 mg, 750 mg, and 1,000 mg chewable tablets on back order and the company estimates a release date of early-April 2025.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.